TY - JOUR
T1 - ‘Never waste a crisis’
T2 - a commentary on the COVID-19 pandemic as a driver for innovation in maternity care
AU - van den Berg, L. M. M.
AU - Thomson, G.
AU - de Jonge, A.
AU - Balaam, M. C.
AU - Moncrieff, G.
AU - Topalidou, A.
AU - Downe, S.
AU - the ASPIRE COVID-19 Team
AU - Ellison, George
AU - Fenton, Alan
AU - Heazell, Alexander
AU - Kingdon, Carol
AU - Matthews, Zoe
AU - Severns, Alexandra
AU - Wright, Alison
AU - Akooji, Naseerah
AU - Cull, Jo
AU - Crossland, Nicola
AU - Feeley, Claire
AU - Franso, Beata
AU - Heys, Steph
AU - Nowland, Rebecca
AU - Sarian, Arni
AU - Booker, Maria
AU - Sandall, Jane
AU - Thornton, Jim
AU - Lynskey-Wilkie, Tisian
AU - Wilson, Vanessa
AU - Abe, Rebecca
AU - Awe, Tinuke
AU - Adeyinka, Toyin
AU - Bender-Atik, Ruth
AU - Brigante, Lia
AU - Brione, Rebecca
AU - Cadée, Franka
AU - Duff, Elizabeth
AU - Draycott, Tim
AU - Fisher, Duncan
AU - Francis, Annie
AU - Franx, Arie
AU - Frith, Lucy
AU - Griew, Louise
AU - Harmer, Clea
AU - Homer, Caroline
AU - Knight, Marian
AU - Lokugamage, Amali
AU - Mansfield, Amanda
AU - Marlow, Neil
AU - Mcaree, Trixie
AU - Monteith, David
AU - Reed, Keith
AU - ASPIRE COVID-19 team
N1 - Funding Information: This research is funded by the Economic and Social Research Council (ESRC), as part of UK Research and Innovation's rapid response to COVID‐19 (grant number ES/V004581/1). Full details of the main study are available via ResearchRegistry (researchregistry5911) and via UKRI Gateway ( https://gtr.ukri.org/projects?ref=ES%2FV004581%2F1 ).
PY - 2022/1
Y1 - 2022/1
N2 - The coronavirus (COVID-19) pandemic has resulted in rapid changes in many areas of health care worldwide.1 Some organisational and governance controls on innovation have been relaxed, to enable rapid adaptation to changing circumstances. The speed of innovation raises a range of ethical, governance and organisational issues. It is important to assess what changes have been instituted, which ones should be maintained, and how to encourage effective innovations in future.
AB - The coronavirus (COVID-19) pandemic has resulted in rapid changes in many areas of health care worldwide.1 Some organisational and governance controls on innovation have been relaxed, to enable rapid adaptation to changing circumstances. The speed of innovation raises a range of ethical, governance and organisational issues. It is important to assess what changes have been instituted, which ones should be maintained, and how to encourage effective innovations in future.
UR - http://www.scopus.com/inward/record.url?scp=85119670434&partnerID=8YFLogxK
U2 - https://doi.org/10.1111/1471-0528.16996
DO - https://doi.org/10.1111/1471-0528.16996
M3 - Comment/Letter to the editor
C2 - 34758179
SN - 1470-0328
VL - 129
SP - 3
EP - 8
JO - BJOG: An International Journal of Obstetrics and Gynaecology
JF - BJOG: An International Journal of Obstetrics and Gynaecology
IS - 1
ER -